Science
Mechanism of Action
This ingredient functions by targeting tyrosinase, a key enzyme in the melanin synthesis pathway, thereby inhibiting melanin production and promoting skin lightening. Beyond this primary action, Methyl Dihydroxybenzoate exhibits radical-scavenging capabilities, indicative of its antioxidant potential. It is also noted for a lower cytotoxic and mutagenic profile compared to hydroquinone.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Methyl Dihydroxybenzoate maintains stability within a pH range of 3.5 to 7.0. It should be incorporated into the water phase of formulations, and exposure to temperatures exceeding 60°C must be avoided during processing.
Safety
Safety Profile
EWG Skin Deep assesses this ingredient with 'LOW' concern across categories including cancer, allergies & immunotoxicity, developmental and reproductive toxicity, and use restrictions, based on limited dermal toxicity evidence from ECHA. However, ECHA classifies it as causing skin irritation (Skin Irrit. 2) and serious eye irritation (Eye Irrit. 2), with potential to cause respiratory irritation (STOT SE 3). It carries a WGK (Water Hazard Class) of 3, indicating severe aquatic hazard.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While offering potential skin-lightening and antioxidant benefits, the ingredient's classification as a skin and eye irritant, coupled with insufficient specific clinical efficacy data at precise concentrations and an unreviewed CIR status, makes its inclusion questionable for precision formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources